- Home
- BIPC vs ALKS Comparison
BIPC vs ALKS Comparison
Compare BIPC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIPC
- ALKS
- Stock Information
- Founded
- BIPC 2019
- ALKS 1987
- Country
- BIPC United States
- ALKS Ireland
- Employees
- BIPC N/A
- ALKS N/A
- Industry
- BIPC Marine Transportation
- ALKS Biotechnology: Pharmaceutical Preparations
- Sector
- BIPC Consumer Discretionary
- ALKS Health Care
- Exchange
- BIPC Nasdaq
- ALKS Nasdaq
- Market Cap
- BIPC 4.7B
- ALKS 4.8B
- IPO Year
- BIPC N/A
- ALKS 1991
- Fundamental
- Price
- BIPC $39.82
- ALKS $31.29
- Analyst Decision
- BIPC
- ALKS Buy
- Analyst Count
- BIPC 0
- ALKS 13
- Target Price
- BIPC N/A
- ALKS $38.85
- AVG Volume (30 Days)
- BIPC 798.2K
- ALKS 1.6M
- Earning Date
- BIPC 01-01-0001
- ALKS 07-23-2025
- Dividend Yield
- BIPC 4.33%
- ALKS N/A
- EPS Growth
- BIPC N/A
- ALKS N/A
- EPS
- BIPC N/A
- ALKS 2.09
- Revenue
- BIPC $3,693,000,000.00
- ALKS $1,513,770,000.00
- Revenue This Year
- BIPC $8.95
- ALKS N/A
- Revenue Next Year
- BIPC $6.21
- ALKS $4.11
- P/E Ratio
- BIPC N/A
- ALKS $14.95
- Revenue Growth
- BIPC 26.99
- ALKS N/A
- 52 Week Low
- BIPC $32.08
- ALKS $22.90
- 52 Week High
- BIPC $43.26
- ALKS $36.45
- Technical
- Relative Strength Index (RSI)
- BIPC 62.28
- ALKS 57.40
- Support Level
- BIPC $38.92
- ALKS $29.70
- Resistance Level
- BIPC $40.00
- ALKS $31.76
- Average True Range (ATR)
- BIPC 0.91
- ALKS 0.75
- MACD
- BIPC -0.04
- ALKS 0.01
- Stochastic Oscillator
- BIPC 79.21
- ALKS 81.64
About BIPC Brookfield Infrastructure Corporation
Brookfield Infrastructure Corp is an indirect subsidiary of the partnership of the diversified infrastructure owner and operators. Its business is comprised of a U.K. regulated distribution operation, a Brazilian regulated natural gas transmission operation and an international intermodal logistics operation. Geographically, the company generates a majority of its revenue from Brazil and rest from United Kingdom and the United States.
About ALKS Alkermes plc
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.